106 157

Cited 0 times in

Retinal Vascular Caliber Changes on OCT after Intravitreal Bevacizumab Injection in Diabetic Macular Edema.

DC FieldValueLanguage
dc.contributor.author김성수-
dc.contributor.author김형은-
dc.date.accessioned2014-12-19T17:54:23Z-
dc.date.available2014-12-19T17:54:23Z-
dc.date.issued2012-
dc.identifier.issn0378-6471-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/92280-
dc.description.abstractPURPOSE: To investigate retinal vascular caliber changes with Spectral Domain OCT after intravitreal bevacizumab injection in diabetic macular edema patients. METHODS: Thirty-four eyes of 29 diabetic macular edema patients who were intravitreously injected with bevacizumab (1.25 g/0.05 ml) were studied. Twenty-four fellow eyes of 24 patients with bevacizumab injection were also recruited as a control group. We measured retinal vascular caliber a distance of 0.5-1 disc sizes from the disc margin with Spectral Domain OCT at baseline and 1-month and 3-month follow-up visits. Central macular thicknesses were also measured. RESULTS: Over the 3 months of study, there was a significant reduction of arteriolar caliber compared to baseline (p = 0.024), There was significant reduction of venular caliber at 1 month (p = 0.001) and 3 months (p = 0.000) compared to baseline. Venular caliber reduction at the 3-month follow-up was significantly correlated with central macular thickness (R = 0.487, p = 0.003). CONCLUSIONS: Retinal venular caliber reduction was significant at 1- and 3-month follow-up, and arteriolar caliber reduction was significant at 3-month follow-up compared to baseline. After 3 months of treatment, venular caliber reduction was correlated with reduction of central macular thickness.-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfJournal of the Korean Ophthalmological Society-
dc.relation.isPartOf대한안과학회지-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleRetinal Vascular Caliber Changes on OCT after Intravitreal Bevacizumab Injection in Diabetic Macular Edema.-
dc.title.alternative당뇨황반부종에서 안내 베바시주맙 치료 후 빛간섭단층촬영을 이용한 망막 혈관 직경의 변화-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Ophthalmology (안과학)-
dc.contributor.googleauthor김영준-
dc.contributor.googleauthor김형은-
dc.contributor.googleauthor송원경-
dc.contributor.googleauthor김성수-
dc.identifier.doi10.3341/jkos.2012.53.2.262-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00571-
dc.contributor.localIdA01153-
dc.relation.journalcodeJ01838-
dc.contributor.alternativeNameKim, Sung Soo-
dc.contributor.alternativeNameKim, Hyoung Eun-
dc.contributor.affiliatedAuthorKim, Sung Soo-
dc.contributor.affiliatedAuthorKim, Hyoung Eun-
dc.citation.volume53-
dc.citation.number2-
dc.citation.startPage262-
dc.citation.endPage267-
dc.identifier.bibliographicCitationJournal of the Korean Ophthalmological Society (대한안과학회지), Vol.53(2) : 262-267, 2012-
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실)

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.